Videos uploaded by user “Proactive Investors Stocktube”
Plug Power CEO says fuels cells will soon dominate electric vehicles
Plug Power Inc (NASDAQ:PLUG) CEO Andy Marsh tells Proactive Investors the fuel cell manufacturer, whose customers include Amazon (NASDAQ:AMZN) and Walmart (NYSE:WMT), says in the next five years, fuels cells will begin to dominate electric vehicles like forklifts, delivery vans, and other vehicles on the road for eight to 15 hours a day. The Latham, New York company replaces lead acid batteries to power electric vehicles with hydrogen fuel cells. Marsh says investors should expect news flow from the company in the next six months indicating the company would be deploying vehicles on the road with some "good partners."
Namaste Technologies addresses recent challenges as they look to grow in the future
Namaste Technologies (CVE:N) Interim CEO Meni Morim and Chief Strategies Officer Darren Gill joined Proactive Investor's Steve Darling from Toronto to provide a corporate update on Namaste after a series of corporate changes. Morim addressed the recent parting of ways with the company's auditors and what the focus of Namaste is going forward. Gill told Proactive about their recent move in acquiring 49 percent of Choklat and how this first in to their new model at Namaste.
Seelos Therapeutics shares soar on acquisition of Parkinson's candidate license created at UCLA
Seelos Therapeutics Inc (NASDAQ:SEEL) CEO Dr. Raj Mehra tells Proactive Investors the company has acquired an exclusive license to the rights to a potential Parkinson’s disease therapy created by researchers at the University of California, Los Angeles. Mehra said the therapy, known as SLS-007, may slow the progression of Parkinson's disease. He said the company may soon perform studies in mice. Shares of the New York-based biotech rose more than 40% on Friday.
Danakali “shovel-ready” at Colluli following execution of US$200m debt finance mandate
Danakali Ltd (ASX:DNK) (LON:DNK) executive chairman Seamus Cornelius updates Proactive Investors on the potash developer’s recent execution of a mandate to provide fully underwritten debt finance facilities of US$200M to fund and construct its Colluli Potash Project in Eritrea. “Given that we’re in Africa, if you were to take a market that is a specialist in funding African projects then that is probably London,” says Cornelius regarding Danakali’s recent AIM-listing. He continues, “getting the debt now with $200 million under the mandate letter, that helps us as well. “Where we are in terms of the project is we are shovel-ready, so as soon as we secure the full funding we will start construction – the construction will take two years and then we’ll be in production [in] 2021.”
Graphite demand 'about to enter a period of rapid growth and improving prices'
Roskill's Kerry Satterthwaite and Suzanne Shaw discuss with Proactive Investors their Natural & Synthetic Graphite Global Industry, Markets & Outlook 2018 report. They say rapid growth in demand for natural flake graphite and synthetic graphite in the lithium-ion battery industry is now forecast to underpin total graphite demand growth of 5–7% per year between 2017 and 2027.
Melius Research: Nelson Peltz signing on to Aurora Cannabis is a 'good move'
Melius Research Founding Partner Rob Wertheimer joined Proactive Investors in the New York studio today to talk about the equity research company beginning coverage of the cannabis sector and trends he sees in the industry. Wertheimer says Aurora Cannabis Inc (NYSE: AC) adding billionaire activist investor Nelson Peltz as an advisor is a good move, as the savvy deal-maker will likely help the cannabis giant make deals and alliances.
Bulls, Bears & Brokers: Tony Locantro on Australia's housing market woes
Tony Locantro, stock market commentator and investment manager at Alto Capital, speaks to Proactive Investors about Australia's troubled housing market, reflecting on house prices and trends in earlier decades. "This generation has really lucked out and it's the baby boomers that bought, say pre-95, that have had a lotto-style win from sitting on their backsides," says Locantro. He continues, "People believe we're in this new paradigm of permanently high prices and someone said that before the 1929 crash. "I think Australia is going to deleverage - we have our debt relative to income at only 190%, that is probably the highest debt level on the planet, and all we're doing is buying rubbish items to impress people we don't like."
Lupuzor could treat a number of diseases, says creator
Sylvaine Muller, creator of ImmuPharma PLC’s (LON:IMM) lead drug candidate Lupuzor, tells Proactive Investors the treatment is “unique” in its treatment for auto-immune disease lupus, as it only targets only the autoimmune system, and not the immune system. But, she adds, “we think that we can open up the indications in which the peptide [molecule] could be effective”. “We have already started some experiments,” Mulller says, which will target a range of diseases including inflammatory, chronic, those related to autoimmunity and those that aren’t - like asthma. “We have first indication that are extremely promising also in these indications,” she adds.
Bulls, Bears & Brokers: Tony Locantro updates on Australian housing markets
Tony Locantro, stock market commentator and investment manager at Alto Capital, updates Proactive Investors on the state of Australia's housing market. Locantro has wagered with prominent Australian economist Stephen Koukoulas on the matter, after initially extending the bet to Martin North, principal of Digital Finance Analytics (DFA), following his appearance on a 60 Minutes Australia segment called 'Bricks and Slaughter.' For all of Tony's Tips and insights, watch our full video interview.
Argo Blockchain's Bixby details partnership with leading crypto-miner HIVE
Argo Blockchain PLC's (LON:ARB) chairman Jonathan Bixby discusses a share swap deal that's been struck with a headline value of £5.1mln with a company called HIVE Blockchain. HIVE is a business-to-business mining service provider aimed at large-scale enterprise and institutional customers. The pair plan to pool capacity.
The Green Organic Dutchman achieves first commercial product sales in Canada
The Green Organic Dutchman Holdings Ltd's (TSE:TGOD) (OTCMKTS:TGODF) VP of Marketing Andrew Pollock tells Proactive Investors the cannabis company has begun shipping several hundred kilograms of cannabis to a national network of medical patients, marking a major milestone in the company’s production strategy. Pollock says the feedback from consumers has been 'terrific' and TGOD will be working with patients on a regular cadence to fulfill the group's orders.
Lightwave Logic working to make the internet faster and more energy efficient
Lightwave Logic Inc (OTCMKTS:LWLG) CEO Michael Lebby joined Proactive's Andrew Scott at the Spring Investor Summit 219 in New York City. Lightwave is developing materials and devices for optical datacom and telecom hardware suppliers
iAnthus updates investors on activities in six US states
iAnthus Capital Holdings (CSE:IAN, OTCQB:ITHUF) CEO Hadley Ford tells Proactive Investors the cannabis company, which owns, operates and partners with licensed cannabis operations throughout the US, has expanded licensed cannabis cultivation operations, processing and dispensary facilities into six states. Ford updated investors on iAnthus's activities in all six states, and referenced the company's recent groundbreaking on its 39,500 sq. ft. medical cannabis cultivation and processing facility in Warwick, New York. Ford will be presenting to investors at Proactive Investor's CannaJam™ 2018 conference in New York, on September 12.
Valens GroWorks takes major step forward with with release of record Q-1 Earnings
Valens GroWorks (CSE VGW-OTC:VGWCF) Executive VP of Strategy and Investments Everett Knight joined Steve Darling from Proactive Investors Vancouver on Skype to talk about Valens record earnings in Q-1 of 2019. Knight talked about what has gone right for the company so far in 2019. Knight also addressed their latest extraction deal and how it is another example of how the company is setting themselves up for the future.
Admedus COO encouraged by initial results from Phase II herpes vaccine trial
Admedus Ltd's (ASX:AHZ) chief operating officer Julian Chick talks to Proactive Investors on the interim Herpes Simplex Virus Phase II clinical trial data. The blinded trial provided data from the first 20 patients to receive at least three vaccinations in the randomised, placebo–controlled HSV-2 vaccine Phase II study. Chick says he is “very encouraged” by the first set of results, which shows the study is “going in the right way and we are seeing what we want to see”.
Metalla Royalty & Streaming Ltd lays out 2019 portfolio plans
Metalla Royalty & Streaming Ltd (CVE:MTA) CEO Brett Heath tells Proactive Investors the Vancouver-based company's bulk of its portfolio is in development, Heath saying these development assets will drive the growth over the next year. Heath adds within the company's portfolio, two to four more of its companies will be in production this year. Heath plans to continue investments into North America within the tier 1 mining jurisdiction.
Antibe Therapeutics is a potential game changer in pain management
Antibe Therapeutics (CVE:ATE, OTCQB:ATBPF) CEO Dan Legault joined Steve Darling from Proactive Investors Vancouver to talk about a biotech company with a pipeline of drugs targeting pain and inflammation. Antibe's pipeline addresses significant unmet medical needs, especially concerning the safety and addictive properties of today's pain therapeutics. Legault also chatted with Proactive about a recently published paper in the British Journal of Pharmacology, providing extensive information about the successful Phase 2B safety trial for its lead drug.
The Green Organic Dutchman signs hemp extraction deal with Valens GroWorks
The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCQX:TGODF) VP of Marketing Andrew Pollock tells Proactive Investors the company has struck a multi-year extraction services contract with Valens GroWorks Corporation (CSE:VGW) (OTCMKTS:VGWCF). Pollock says TGOD hopes to be ready with a product in Canada by early Q3 2019.
Here's what CannTrust needs to do to hit $10, says Bob Byrne
Proactive Investors contributor Bob Byrne says he believes CannTrust Holdings Inc (TSE:TRST) (OTCMKTS:CNTTF) is a cannabis company to watch. Byrne says the stock is cheap at about $6 compared to bigger cannabis stocks like Tilray (NASDAQ:TLRY ). Byrne says for the stock to move above $10, the Canntrust needs to uplist to a major US exchange and secure the necessary permits to complete the buildout of its Ontario, Canada facility.
The Green Organic Dutchman sees a path forward to become a player in the U.S.
The Green Organic Dutchman (TSE:TGOD) CEO Brian Athaide joined Steve Darling from Proactive Investors to discuss TGOD’s strategic investment into the US beverage space as a co-founding investor and strategic partner in the newly formed Califormulations LLC Athaide explains why they decided to do this and how this will fit into the Green Organic Dutchman’s growth strategy moving forward.
Tim Collins calls Andrew Left the 'Bond villain' of the financial world
Proactive Investors Contributor Tim Collins says notorious short-seller Citron Research's Andrew Left is a Bond villain for suggesting investors short-sell cannabis company Village Farms International Inc (NASDAQ:VFF) (TSE:VFF) targeting it at $1. Collins argues Left's attempted take-down of the company is for shock value, and uses unsubstantial accusations.
How to Invest in Mining: Proactive Investors presents a beginners guide
In the first of a series of “How to” videos, Proactive Investors presents a beginners guide to investing in the mining sector. Featuring Amanda Van Dyke, Women in Mining; Jeremy Wrathall, Investec and Niall Pearson, Hybridan.
Capital Network analyst on Oriole Resources as it refocuses on Africa
Capital Network's Christopher Ecclestone discusses Oriole Resources PLC (LON:ORR) - an exploration company, operating in Africa and Europe but with some legacy exposure through investment in, and royalties on, the projects it incubated in Turkey since its listing in 2006. Oriole's focused on early-stage gold exploration in Cameroon and the more advanced Dalafin gold project in Senegal, where Iamgold has the option to spend US$8mln to earn a 70% interest.
Great Bear Resources finds new discovery at Dixie Project in Red Lake, Ontario
Great Bear Resources (CVE:GBR) President and CEO Chris Taylor dropped into the Vancouver studio of Proactive Investors to tell Steve Darling that Great Bear has made a new high-grade gold discovery at its Dixie project in Red Lake, Ontario. Taylor tells Proactive where the discovery was made, in relation to the other zones the company is looking at, including the Hinge Zone.
Danakali chairman updates on financing with construction to start  before year-end
Seamus Cornelius, executive chairman of Danakali Ltd (ASX:DNK) (LON:DNK) (OTCMKTS:SBMSF), caught up with Proactive London after agreeing a US$200 million syndicated loan facility to go towards construction of its Colluli Potash Project in Eritrea. The fully-underwritten loan facility led by African development financial institutions (DFIs) African Export-Import Bank and Africa Finance Corporation has a series of milestones Danakali must satisfy to qualify. Colluli has a massive ore reserve estimate of 1.1 billion tonnes grading 10.5% potassium oxide for 203 million tonnes of contained sulphate of potash equivalent.
The Green Organic Dutchman reveals strong cash position in Q4 highlights
The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS: TGODF) Chief Financial Officer Sean Bovingdon tells Proactive Investors that it ended 2018 with a strong balance sheet and liquidity, including C$263.5 million in cash and restricted cash, to continue to bankroll its expansion and international growth. Bovingdon commented on what TGOD needs to do to hit Jefferies analyst Owen Bennett's price target of C$6.10.
CelSci updates Phase 3 clinical trial of Advanced Head and Neck Cancer treatment
CEL-SCI Corporation (NYSE:CVM) CEO Geert Kersten sat down with Proactive Investors at the ThinkEquity Conference in New York. The Virginia-based biotech treats patients who are newly diagnosed with advanced primary squamous cell carcinoma of the head and neck with its drug Multikine before they receive surgery, radiation and/or chemotherapy.
Green Organic Dutchman gets green light from Hamilton City council to operate facility
The Green Organic Dutchman (TSE:TGOD) Vice President of Government Affairs and Social Responsibility Ian Wilms joined Steve Darling from Proactive Investors on Skype from Ontario to talk about their settlement with Hamilton City Council in regards to their facility in Ancaster, Ontario. Wilms talked about what this means for TGOD and also talks about the timeline going forward.
WeedMD expands production with 25 acre outdoor cannabis cultivation
WeedMD (CVE:WMD-OTCQX:WDDMF) CEO Keith Merker joined Proactive Investors Vancouver's Steve Darling from Toronto with news the cannabis company is applying to expanded their Strathroy licence to 25 acres of outdoor cultivation. In 2019, Phase I will be brought online, representing more than 25 acres of production, with an additional 25 acres planned for Phase II in 2020.
CytoDyn aims to be 'paradigm-shifting' in cancer management with its platform drug leronlimab
CytoDyn Inc (OTCQB:CYDY) CytoDyn CEO Nader Pourhassan and CMO Dr. Richard Pestell sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The biotechnology company is focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV.
Rare Earths market analysis from Roskill
Why are Rare Earths increasingly important both to China and the rest of the world? How is supply and demand met and which processes are holding up that supply chain from functioning optimally? What about the importance of secondary supply and recycling? All these questions and more are put to Roskill's Rare Earth's analyst David Merriman, who brings Proactive London up to date about this fascinating growing market and why investors should be keeping a sharp eye on it.
The Green Organic Dutchman CFO says its Jamaican operation is growing
The Green Organic Dutchman Holdings Ltd (TSX:TGOD) (OTCQX:TGODF) CFO Sean Bovingdon tells Proactive Investors the organic cannabis company is seeing growth in its Jamaican operations. The Canadian cannabis company acquired a 49.2% stake in Jamaican cannabis company Epican last June, and Bovingdon talks about the highlights with Epican since then.
Aurora Cannabis offshoot Australis Capital making its mark in the US
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) CEO Scott Dowty and CFO Michael Carlotti tell Proactive Investors the investment firm focused on the cannabis sector is making its mark in the US, saying the company's most recent investment was in its acquisition of California-based cannabis brand Mr. Natural Productions Inc. Australis is a spinoff of Aurora Cannabis (NYSE: ACB), and continues to work closely with the cannabis giant.
Australis Capital makes strategic cannabis acquisition in Nevada
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) CEO Scott Dowty tells Proactive Investors the cannabis investment firm has increased its stake in cannabis dispensary operator Body and Mind Inc (CSE:BAMM) and acquired cannabis company Green Therapeutics LLC, including its facility in Las Vegas, Nevada. Dowty adds Aurora Cannabis Inc (NYSE:ACB) will leverage Australis's infrastructure in Vegas as it relates to the cannabis giant's newly announced partnership with UFC.
Union Jack's David Bramhill 'over the moon' with significant West Newton result
Union Jack Oil PLC's (LON:UJO) David Bramhill speaks to Proactive London's Andrew Scott after revealing what could be a potentially transformational result as the West Newton appraisal well confirmed a substantial hydrocarbon accumulation. The West Newton A-2 conventional appraisal well, located in east Yorkshire, encountered a 65 metre (net) interval in the Kirkham Abbey formation which was its main target.
Bulls, Bears & Brokers: Alto Capital's Tony Locantro reveals his current top stock tips
Tony Locantro, stock market commentator and investment manager at Alto Capital, provides Proactive Investors with his most comprehensive list yet of small cap stock picks - which he calls "the nauseating nine." To hear all of Tony's Tips, and his cases for them, watch our full video interview.
Sirius Minerals PLC chief discusses DFS and York Potash financing
The long-awaited definitive feasibility study (DFS) for Sirius Minerals PLC's (LON:SXX) York Potash Project in North Yorkshire has underscored its huge potential. The report says its net present value today is US$15bn using a 10% discount rate. Managing Director, Chris Fraser, tells Proactive that the firm is “ready to go” on construction of the project, with the company now looking to how it will finance its development. He adds that the projects biggest competitive advantage is its margins, with the company expecting “around 70% margins up to 85% - and it’s very difficult to find projects or companies that come even close to those margins.”
Glint reintroducing gold as money with launch of 'world first' payments app
Ben Davies, co-founder of Glint, spoke to Proactive as they launched their debit card and app (Glint Pay) which allows consumers to pay for goods and services with gold. The fintech group's teamed up with Lloyds Banking Group to create the app which allows people to load credit onto their card which can then be used to buy part of a physical piece of gold. Glint is regulated by the Financial Conduct Authority (FCA).
Weekend Unlimited getting to major product launch in Washington State
Weekend Unlimted (CSE:POT) President and CEO Chris Backus joined Steve Darling from Proactive Investors Vancouver to talk about the company's launch of their weekend products in Washington State. Backus also gave Proactive an update on their Northern Lights Organic facility on Northern British Columbia what will be happening over the next few years.
FDA accepted CytoDyn’s request and plan to submit BLA on rolling basis
CytoDyn Inc. (OTCQB:CYDY) President and CEO Dr. Nader Pourhassan joined Steve Darling from Proactive Investors Vancouver on Skype to talk about encouraging news that the FDA will allow CytoDyn to submit on a rolling basis its planned Biologics License Application for Leronlimab. This is a humanized IgG4 mAb that is subcutaneously injected to block HIV-1 from entering and infecting immune cells. Pourhassan told Proactive how rare this is for a company their size and when the first submissions will be made.
Yellow Cake Plc giving investors unique exposure to uranium price
Yellow Cake Plc (LON:YCA) made its debut on AIM in July this year raising US$200mln (£151mln). Yellow Cake – a nickname for uranium – is backed by Bacchus Capital, the corporate finance boutique set up in 2016 by a group of senior bankers led by Peter Bacchus. Chief executive Andre Liebenberg tells Proactive that their long-term supply contract with Kazatomprom has allowed them to secure a highly significant and strategic position in physical uranium, at a competitive price.
ContraVir Pharmaceuticals CEO excited to get Hepatitis B drug to patients in new study
ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) CEO James Sapirstein tells Proactive Investors the bio-pharmaceutical company has just announced a new formula of its Hepatitis B drug tenofovir exalidex (TXL) and can start delivering the drug to patients in a dose-range finding study, looking to be in Phase 3 trials sometime in the near future. Sapirstein also updated investors on the New Jersey based company's other Hepatitis B vaccine treatment called CRV-431, saying the FDA approved the company's investigational new drug application (IND).
1933 Industries adds another major brand following deal with hip-hop artist Kurupt
1933 Industries (CNSX:TGIF-OTCQX:TGIFF) COO of U.S. Operations Chris Rebentisch joined Steve Darling from Proactive Investors Vancouver on Skype from Nevada to talk about a number of deals the company has signed with some major stars, hip-hop artist Kurupt and skateboarding legend Tony Hawk's Birdhouse Skateboards. Rebentisch also providing Proactive with a construction update on their new advanced cannabis cultivation facility and when they will move in and start producing.
Sproutly Canada adds senior beverage exec Michael Bellas to its board
Sproutly Canada Inc (OTCQB:SRUTF) CEO Keith Dolo tells Proactive Investors the Vancouver-based cannabis company is adding seasoned beverage executive Michael Bellas, CEO and founder of New York-based Beverage Marketing Company, to its board of directors. Dolo says Sproutly, which is already a licensed cannabis producer, is now positioning itself to take advantage of its "APP technology," which will allow the company to create a water-soluble cannabis solution that will then be used in beverages to sell in Canada.
Valeura Energy Inc - Oil Capital Conference March 2019
Valeura Energy Inc (TSX:VLE) CEO Sean Guest presents to investors at the Oil Capital Conference in London - March 2019. For more information visit www.valeuraenergy.com
Graphene set to change everything says Versarien boss
From 3-D printing to sport, ‘wonder material’ graphene is set to change how we live according to Versarien PLC (LON:VRS) boss and founder Neil Ricketts. This year alone Versarien has started to work with former Olympian Kristan Bromley to develop graphene-enhanced skeleton boards, CT Engineering on aero parts and print specialist Absolute Engineering for graphene-based inks. Ricketts though, tells Proactive this is just the start as the understanding of these new materials and their uses is still at its very formative stages. For Versarien, having completed its IPO, raised funds and on track to break even, it all adds to a great place to be currently he explains.
GeoVax Labs developing a therapy that potentially cures Hepatitis B
GeoVax Labs Inc. (OTCQB:GOVX) Chairman & CEO David Dodd sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The clinical-stage biotechnology company is developing human vaccines against infectious diseases using its Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform.
CytoDyn take major step forward filing trial protocol for HIV Monotherapy
CytoDyn (OTCQB:CYDY) CEO Nader Pourhassan joined Steve Darling from Proactive Investors Vancouver on Skype to bring news the company has filed to the FDA, the pivotal trial protocol for leronlimab as a monotherapy for HIV patients. Pourhassan also shared details about the work involved to get to this point and what the next stage is.
Eco Atlantic's Gil Holzman welcomes strong investor interest in US$17mln fundraise
Gil Holzman, chief executive of Eco Atlantic Oil & Gas Ltd (LON:ECO) (CVE:EOG), speaks to Proactive London's Andrew Scott after raising US$17mln of new funds to cover its participation in a possible expansion to the exploration drilling campaign offshore Guyana. Eco will now be able to fund its share of up to four additional exploration or development wells, perhaps indicating confidence among the joint venture partners ahead of the first phase of wells.
FAR Ltd turns to The Gambia as SNE oilfield approaches commercialisation milestone
FAR Ltd (ASX:FAR) managing director Cath Norman speaks to Proactive Investors about the oil and gas exploration company’s exciting advancements off the west coast of Africa. The company’s efforts are currently focused on The Gambia, and in particular on the Samo prospect. “Drilling an 800 million barrel prospect is large by any company standards... when you consider that at the moment we have a net 140 million barrels to our name in Senegal, and our market cap’s $500 million, it’s wonderful to think about what our market capitalisation could be after we’ve drilled this Gambian well and have access to maybe another 300 million barrels to FAR’s name. And we’ll have the results of that well by mid to late November at the latest, if we spud on October 1,” says Norman. FAR Ltd’s Senegalese operations are much more advanced, approaching a key milestone on the path to commercialisation. Norman explains, “we’ve got past the three principal hurdles of size, deliverability, and connectivity; so we understand everything about the oilfield now enough to progress to development. We are in a position today where we’ll be submitting the discoveries evaluation report to the government in about two weeks, which is a statement of commerciality, which I know a lot of our shareholders will be very pleased to see. And with that we’ll be progressively releasing some information about the final size for the development, and also the economics. The field will be developed in a phased development approach... we’ll be looking to get approval of our development plan by the end of this year, we’ll take the final investment decision in mid-2019, and then we’ve got an ambition to have first oil in about 2022.”